HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of ventricular arrhythmias.

Abstract
Underlying causes of ventricular tachycardia (VT) or complex ventricular arrhythmias (VA) should be treated if possible. Anti-arrhythmic drugs should not be used to treat asymptomatic patients with complex VA and no heart disease. Beta blockers are the only antiarrhythmic drugs that have been documented to reduce mortality in patients with VT or complex VA. Radiofrequency catheter ablation of VT has been beneficial in treating selected patients with arrhythmogenic foci of monomorphic VT. The automatic implantable cardioverter-defibrillator (AICD) is the most effective treatment for patients with life-threatening VT or ventricular fibrillation. The American College of Cardiology/American Heart Association class I indications for an AICD are discussed. Other indications for an AICD are discussed. Patients with AICDs should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing at a rate of 70/minute. Patients with AICDs should be treated with beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin blockers.
AuthorsW S Aronow
JournalMinerva cardioangiologica (Minerva Cardioangiol) Vol. 58 Issue 6 Pg. 657-76 (Dec 2010) ISSN: 0026-4725 [Print] Italy
PMID21135807 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Arrhythmia Agents
  • Calcium Channel Blockers
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Anti-Arrhythmia Agents (therapeutic use)
  • Calcium Channel Blockers (therapeutic use)
  • Cardiac Resynchronization Therapy (methods)
  • Catheter Ablation
  • Coronary Artery Bypass
  • Death, Sudden, Cardiac (prevention & control)
  • Defibrillators, Implantable
  • Drug Therapy, Combination
  • Heart Conduction System (physiopathology)
  • Humans
  • Prevalence
  • Prognosis
  • Severity of Illness Index
  • Survival Analysis
  • Tachycardia, Ventricular (diagnosis, epidemiology, physiopathology, therapy)
  • Treatment Outcome
  • Ventricular Fibrillation (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: